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SHORT REPORT
An evaluation of different meta-analysis approaches
in the presence of allelic heterogeneity
Jennifer Asimit1, Aaron Day-Williams1, Lina Zgaga2,3, Igor Rudan2, Vesna Boraska1,4 and Eleftheria Zeggini1
Meta-analysis has proven a useful tool in genetic association studies. Allelic heterogeneity can arise from ethnic background
differences across populations being meta-analyzed (for example, in search of common frequency variants through genome-
wide association studies), and through the presence of multiple low frequency and rare associated variants in the same
functional unit of interest (for example, within a gene or a regulatory region). The latter challenge will be increasingly
relevant in whole-genome and whole-exome sequencing studies investigating association with complex traits. Here, we
evaluate the performance of different approaches to meta-analysis in the presence of allelic heterogeneity. We simulate allelic
heterogeneity scenarios in three populations and examine the performance of current approaches to the analysis of these
data. We show that current approaches can detect only a small fraction of common frequency causal variants. We also
find that for low-frequency variants with large effects (odds ratios 2–3), single-point tests have high power, but also high
false-positive rates. P-value based meta-analysis of summary results from allele-matching locus-wide tests outperforms
collapsing approaches. We conclude that current strategies for the combination of genetic association data in the presence
of allelic heterogeneity are insufficiently powered.
European Journal of Human Genetics (2012) 20, 709–712; doi:10.1038/ejhg.2011.274; published online 1 February 2012
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INTRODUCTION
The combination of genetic association studies in a meta-analysis
framework can increase power to make novel discoveries. Large-scale
meta-analyses across multiple data sets have become the mainstream
approach to genome-wide association scans (GWAS). These studies have
been successful in identifying common (minor allele frequency (MAF)
Z0.05) genetic variants that underlie a variety of phenotypes and
diseases, and have so far mostly focused on similar-ancestry populations,
primarily of European descent. As more GWAS across diverse popula-
tions of Asian and African ancestry start to accrue, examples of allelic
heterogeneity at established common disease loci begin to emerge,1–4
and the need to develop powerful strategies for meta-analyzing geneti-
cally different populations becomes prominent.5,6 Although large sample
sizes can help guard against false-negative and false-positive results, a
major potential caveat is that allelic heterogeneity across populations
(Figure 1) could lead to the dramatic dilution of power to detect true
positive signals.7 In this work, we evaluate the power of existing methods
for the meta-analysis of data across populations.
Allelic heterogeneity is also poised to be a major concern in whole-
genome and whole-exome sequencing studies investigating the asso-
ciation of low-frequency and rare variants with complex traits.8–11 It is
expected that multiple different causal variants of low frequency will
be found to reside within the same functional units, and that different
alleles will be carried by different individuals across studies. Locus-
wide approaches to detect association and thus increase power have
been proposed, but it is not yet clear whether existing meta-analysis
approaches will be useful in combining data across data sets to
increase power.
Whether trying to identify common variants of small effect sizes or
low-frequency/rare variants with modest effect sizes, large samples are
required and those are likely to be achieved by synthesizing data across
multiple populations. Here we outline and evaluate different strategies
for the meta-analysis of genetic association data in the presence of
allelic heterogeneity. Based on simulated data, we provide insights into
strategies for analyzing common variant signals across data sets and
resequencing studies that aim to identify low-frequency variant
associations in the presence of allelic heterogeneity.
MATERIALS AND METHODS
Case–control data across three populations were simulated under two distinct
allelic heterogeneity scenarios, (a) common causal variants with small effect
sizes (odds ratio (OR) 1. 1–1.2) and (b) low-frequency causal variants with
larger effect sizes (OR 2–3; Table 1). For each replicate of simulated data, an
association analysis was performed in each of the three populations followed
by meta-analysis (Figure 2). For each of the two distinct allelic heterogeneity
scenarios, we simulated 1400 replicates of genotypic and phenotypic data for a
case–control study of 2000 cases and 2000 controls, for three different
populations. To mimic allelic heterogeneity, populations were set to have
different causal variants associated with disease. Causal alleles were set to be
population-specific, that is, they were not present in the other two popula-
tions. When we repeated the simulations allowing causal variants to be
present, but not associated with the phenotype, in all three populations, our
results remained the same qualitatively (data not shown). All replicates where
there was a shared causal allele among populations were excluded from the
meta-analysis, yielding 1025 replicates for the common variant scenario and
1163 replicates for the low-frequency scenario. In population 1, there is one
causal variant, whereas populations 2 and 3 each have two causal variants that
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are not in strong linkage disequilibrium (LD) with one another. For each
scenario, the frequency and OR of the causal alleles are provided in Table 1.
Genotypic data were simulated using the hapsim R package and were based
on pilot study data from the 1000 Genomes Project12 (August 2009 Release,
68 CEU samples) for an arbitrary 150 kb region from chromosome 1 with a
genome-average recombination rate of approximately 1 Mb/cM. We filtered
out variants with quality scores below 10, which resulted in a region consisting
of 110 variants. First, a population of 40 000 haplotypes was simulated such
that the allele frequencies and pair-wise LD mimic those of the specified region
from the 1000 Genomes Project data.13 This approach produces realistic
resequencing data that include variants with MAFs below 0.01; in our region
there were variants with MAF as low as 0.0079. The causal allele(s) were chosen
randomly from among those with a MAF near the setting for the simulation,
and when there were two causal alleles the choice for the second allele was
restricted such that it was not in strong LD with the first causal variant
(r2 o0.4). Individuals were formed by randomly pairing the haplotypes from
the haplotype population.
Case–control status was generated by using a multiplicative model for the
genotype relative risks (RRs) to compute the probability of disease given the
genotype at the causal variant and its RR.14 This probability was then used to
generate a Bernoulli random variable that ascertains an individual as a case
when its value is 1, and a control otherwise. For this reason, it was necessary to
oversample (say, 5N) the number of individuals N to ensure that the desired
number of cases was attained.
The association study was performed for each population separately, using
three different approaches: (a) classical single-variant analysis for each variant
in the region, (b) a collapsing method11 and (c) an allele-matching association
test14 For the single-variant analysis a w2-test of association was carried out at
each variant, resulting in a P-value and OR for independent association of each
variant to phenotype. The latter two methods were locus-based tests, so that
only a single test was performed. There are various versions of the collapsing
method, and all combine information across multiple variant sites into a
univariate test for disease association with an accumulation of rare variants.11,15
In the version we considered, phenotype is modeled as a function of the
indicator variable of rare variants that carry at least one minor allele:
log itPrðYi ¼ 1Þ ¼ a+bIðriÞ; i ¼ 1; . . . ;N
where Yi is the case–control status for individual i, ri denotes the number of rare
variants that carry at least one copy of the minor allele, I(ri)¼1{ ri4 0 } is the
Figure 1 Schematic overview of allelic heterogeneity in a chromosomal
region implicated in disease across three populations. Variants are
represented by dark and light blue boxes. Causal variants are population-
specific (shown in light blue and indicated by arrows, N¼5) and the
strongest signal of association is found for a different variant in each
population (the y axis describes the strength of association).
Table 1 Allele frequency and OR of the simulated common
frequency (MAF Z0.05) and low-frequency (MAF o0.05)
causal variants per population
Common variant
allele frequency OR
Rare variant
allele frequency OR
Population 1 0.30 1.10 0.04 2.0
Population 2 0.15 1.15 0.01 2.0
0.20 1.15 0.01 2.5
Population 3 0.40 1.10 0.02 2.0
0.15 1.20 0.01 3.0
Abbreviations: MAF, minor allele frequency; OR, odds ratio.
Figure 2 Flowchart providing an overview of the analyses carried out.
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indicator variable for the presence of at least one minor allele at any rare variant
for subject i, and b is the expected increase when an individual carries at least
one minor allele at any rare variant compared with one that has a complete
absence of rare minor alleles. Analysis of deviance is used to compare the
maximized likelihoods of the null (b¼0) and unconstrained b models in the
construction of likelihood ratio tests of disease association for an accumulation
of rare variants.
The allele-matching association test considered is the kernel-based associa-
tion test (KBAT),14 which tests for a joint association of multiple variants
(correlated or independent) with a categorical phenotype, without any
assumptions on the directions of individual variant effects. First, similarity
scores yl(ij) between individuals i and j in group l (eg, 1¼cases, 2¼controls) are
determined by using a kernel, such as the Allele Match kernel, which is the
count of shared alleles between the genotypes of two individuals. Let gi be the
genotype score at a specific variant, which is conveniently defined as the
number of reference alleles at the variant, as knowledge of the risk allele is
irrelevant. At a given variant, for individuals iaj in group l with respective
genotypes gl(i) and gl(j), the similarity score yl(ij) takes on values 4 (identical
genotypes), 2 (one homozygous, other heterozygous) and 0 (otherwise). By
defining the kernel in this way, there is no need to have knowledge of the risk
allele at each variant. The similarity scores yl(ij) between individuals i and j in
group l are modeled using a one-way ANOVA model at each variant:
ylðijÞ ¼ m+al; ioj ¼ 1; . . . ; nl; l ¼ 1; 2;
Where m is the general effect for pairs of individuals, al is the group-specific
treatment effect, and to test for disease association the null hypothesis is
H0:a1¼a2. The single-variant test statistic at marker k is the ratio of the between
group sum of squares SSBk and the within group sum of squares SSWk, and the
K-marker KBAT test statistic is
PK
k¼1
SSBk
PK
k¼1
SSWk
:
Clearly the similarity scores yl(ij) are not independent normal random variables,
so that neither the single-variant test statistics nor the KBAT test statistic may
be approximated by an F-distribution. Thus, permutation is required to obtain
the P-value for each locus. For comparison purposes with the collapsing
method, we only include variants with MAF o0.05 in the KBAT.
After completing the association analyses, sets of results were obtained for
each of the three analyzed populations: 110 single-variant P-values and
corresponding ORs, one for each tested variant; collapsing method P-value
and OR; and KBAT P-value (and test-statistic, but no OR). We then carried out
a meta-analysis across the three populations using two different approaches:
(i) OR based (fixed and random effects) and (ii) P-value based (Fisher’s product
method). Methods of fixed effect meta-analysis are based on the mathematical
assumption that every study in the meta-analysis shares a common (or ‘fixed’)
true effect size, and differences in the observed effect sizes are only due to the
random error within in each study. Under this assumption, if every study were
infinitely large, the results of every study would be identical. This is the same as
assuming there is no heterogeneity among the studies. A random effects meta-
analysis makes the assumption that individual studies are sampled from
populations that may have similar, but not identical, true effect sizes. Differ-
ences in observed effect sizes arise from random error as in fixed effects, as well
as true variation in effect size. Conclusions arising from the random effects
analysis could be generalized to a range of populations, whereas those from the
fixed effects are restricted to populations that are identical to those used in the
analysis. Both approaches are of interest in testing whether sufficiently strong
effects in a single population could still emerge as signals upon meta-analysis.
Because of the unavailability of an OR from the KBAT, we only applied a
P-value-based meta-analysis for this method. We used a combination of
in-house scripts and the software GWAMA16 to conduct meta-analyses.
In each replicate, there were five causal loci. For the single-point method, we
report identified loci as the proportion of replicates that detect association with
at least one causal variant. For the collapsing and allele-matching methods, a
nominal significance threshold was kept at 0.05. In single-variant analysis, 110
variant markers were tested and the threshold for variant-specific analysis was
set to 0.00045 (0.05/110).
RESULTS
In the setting of common causal variants with small effect sizes, the
detection of causal variants or loci was unsatisfactory based on single-
variant tests, and power of the meta-analysis approaches to detect at
least one causal variant ranged from 5. 5 to 15.7% (Table 2). The
P-value-based meta-analysis approach was slightly more successful
than the fixed effects OR-based approach (15.7% vs 11.0%), with the
random effects OR-based approach performing worst (5.5%). It is
noteworthy that the meta-analysis of common variants with small
effects in the presence of allelic heterogeneity does not detect associa-
tion with any of the causal variants in 84.3% of the replicates, even in
the appreciable sample size of 6000 cases and 6000 controls. Con-
versely, none of the replicates identified all five causal variants across
the three studied populations (Table 2).
In the low-frequency causal variant scenario, we found that the
meta-analysis of single-point association results had greatest power to
detect at least one of the causal alleles, with the P-value meta-analysis
having 100% power, followed by the fixed effects of OR-based meta-
analysis with 98% power (Table 2). However, these meta-analyses also
gave rise to a very high false-positive rate, with the P-value-based and
fixed effects OR-based approaches identifying at least one false positive
association in 72% and 51.8% of the replicates, respectively. Only 4 out
of 1163 replicates correctly detected association at all five causal variants
through the P-value-based meta-analysis, whereas none of the replicates
achieved this in the OR-based meta-analysis approaches (Table 2).
Table 2 Single-point meta-analysis results summary
Meta-analysis type Power (%)
False-positive
rate (%)
1 Causal
variant found
2 Causal
variants found
3 Causal
variants found
4 Causal
variants found
5 Causal
variants found
MAF Z0.05
P-value based 15.71 14.41 12.49 2.54 0.59 0.10 0
OR based (fixed effects) 11.02 15.51 7.02 2.93 0.88 0.20 0
OR based (random effects) 5.46 10.05 3.71 1.46 0.29 0 0
MAF o0.05
P-value based 100 71.97 19.26 42.65 30.78 6.96 0.34
OR based (fixed effects) 98.28 51.76 57.95 31.99 7.14 1.20 0
OR based (random effects) 6.45 13.93 5.76 0.69 0 0 0
Abbreviations: MAF, minor allele frequency; OR, odds ratio.
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The locus-wide collapsing tests examining low-frequency and rare
variants (MAF o0.05) in aggregate demonstrated lower power to
detect association. Here, the P-value-based meta-analysis method
performed worst with 15.7% power, whereas the OR-based fixed
effects approach performed best with 22.7% power. The allele-matching
method demonstrated clear power advantages, with 74.7% power to
detect association at the locus level, despite the underlying allelic
heterogeneity (Figure 3).
DISCUSSION
Our findings demonstrate the low sensitivity of current approaches to
detect common causal variants in the presence of allelic heterogeneity
when meta-analyzing across genetically heterogeneous populations.
The field of statistical genetics is active in developing and testing new
approaches to overcome these issues and to enable powerful trans-
ethnic mapping.17
We found the choice of methodological approach to detecting low-
frequency variants in the era of whole-exome and whole-genome
sequencing to greatly affect association study power. However, the
power of individual locus-wide methods critically depends on the
allelic architecture of disease. For example, in these simulations there
were only one or two low frequency causal variants in each popula-
tion, and the collapsing method has been designed to perform
optimally in the presence of an accumulation of multiple rare variants.
Single-point approaches to the meta-analysis of low-frequency
variants performed poorly with respect to false-positive rate and,
within the power constraints of our study, almost never detected all
causal alleles. It appears that given a large enough sample size, allele-
matching methods provide good power to detect association at the
locus level in the presence of allelic heterogeneity. As the currently
sparse set of next-generation sequencing empirical data for complex
traits begins to grow, the need for powerful meta-analysis methods
that account for heterogeneity increases. The development of such
approaches will allow the next set of large-scale meta-analyses to take
place, and will therefore pave the way for successful novel locus
discovery.
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Figure 3 Locus-wide meta-analysis results summary.
Meta-analysis and allelic heterogeneity
J Asimit et al
712
European Journal of Human Genetics
